PRESS ANNOUNCEMENT
PHATISA LEADS MBO OF SOUTH AFRICAN-BASED BIOTECHNOLOGY COMPANY – DELTAMUNE 14 January 2022 Phatisa, together with management, has acquired 100% of South African-based biotechnology company Deltamune from HL Hall & Sons Investments, for an undisclosed sum. Established in 1995, Deltamune plays a trusted role in veterinary and public health, by developing and manufacturing vaccines…